Concepedia

Uche Anadu Ndefo

UA

Statistics

Publications

6

Citations

302

H-Index

6

Active since

2008

Affiliations

Texas Southern University(Current)

Uche Anadu Ndefo is an author at Texas Southern University specializing in medicine, pharmacotherapy, and immunology.

Top concepts

Publications per year

2008–2017

6

Publications

6

Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer.

Enock Anassi, Uche Anadu Ndefo · PubMed · 2011 · 154 citations · Full text

, , +22

Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes.

Uche Anadu Ndefo, Nicole O Anidiobi, Angie Eaton · PubMed · 2015 · 65 citations · Full text

, , +7

Pharmacological management of sickle cell disease.

Uche Anadu Ndefo, Angie Eaton Maxwell, Huong Nguyen et al. · PubMed · 2008 · 29 citations

, , +16

Provision of Medication Therapy Management by Pharmacists to Patients With Type-2 Diabetes Mellitus in a Federally Qualified Health Center.

Uche Anadu Ndefo, Aisha Morris Moultry, Portia N. Davis et al. · PubMed · 2017 · 21 citations · Full text

Nebivolol: A new antihypertensive agent

Charnelda L. Gray, Uche Anadu Ndefo · American Journal of Health-System Pharmacy · 2008 · 20 citations

1–5 of 6